saxenda glp 1 agonist (liraglutide) for the Treatment of Obesity, US GLP-1 Agonists for Weight Loss:
Description
HeinzerRVatSMarques-VidalPMarti-SolerHAndriesDTobbackNet al
Cell 185 , 24782494.e2428 (2022)
In response, industry giants Novo Nordisk and Eli Lilly are making substantial investments to expand their production capabilities
[DOI] [PubMed] [Google Scholar] 276.Mace O.J., Schindler M., Patel S
